Guixin Wang1,2, Shuhao Zhang3, Meiling Wang2, Lin Liu1, Yaqian Liu2, Lianjun Tang4, He Bai1, Haidong Zhao5. 1. General Surgery Department, Dalian University Affiliated Xinhua Hospital, Dalian, 116000, China. 2. Breast Surgery Department, The Second Hospital of Dalian Medical University, Dalian, 116000, China. 3. Cardiology Department, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, China. 4. General Surgery Department, Dalian Jinzhou First People's Hospital, Dalian, 116000, China. 5. Breast Surgery Department, The Second Hospital of Dalian Medical University, Dalian, 116000, China. 617410555@qq.com.
Abstract
BACKGROUND: Occult metastases in axillary lymph nodes have been reported to be associated with poor prognosis in patients with breast cancer. However, studies on the prognostic value of occult metastases have shown controversial results. This meta-analysis aimed to evaluate the prognostic significance of occult lymph node metastases in breast cancer. METHODS: Studies published until May, 2020, which retrospectively examined negative lymph nodes by stepsectioning and/or immunohistochemistry, were retrieved from MEDLINE, EMBASE, CNKI, and Cochrane Library databases. The pooled Relative Risk (RR) with 95% confidence interval (95% CI) for overall survival (OS) and disease-free survival (DFS) were calculated to examine the associations between occult metastases and prognosis. RESULTS: Patients with occult metastases in axillary lymph nodes had poorer five-year DFS (RR = 0.930; 95% CI = 0.907-0.954) and OS (RR = 0.972; 95% CI = 0.954-0.990). Furthermore, the DFS (RR = 0.887; 95% CI = 0.810-0.972) and OS (RR = 0.896; 95% CI = 0.856-0.939) of patients with occult metastases were significantly lower after a ten-year follow-up. CONCLUSIONS: Occult metastases in the axillary lymph nodes are associated with poorer DFS andOS of patients with breast cancer. Occult metastases might serve as a predictive factor of survival outcomes in patients with breast cancer.
BACKGROUND: Occult metastases in axillary lymph nodes have been reported to be associated with poor prognosis in patients with breast cancer. However, studies on the prognostic value of occult metastases have shown controversial results. This meta-analysis aimed to evaluate the prognostic significance of occult lymph node metastases in breast cancer. METHODS: Studies published until May, 2020, which retrospectively examined negative lymph nodes by stepsectioning and/or immunohistochemistry, were retrieved from MEDLINE, EMBASE, CNKI, and Cochrane Library databases. The pooled Relative Risk (RR) with 95% confidence interval (95% CI) for overall survival (OS) and disease-free survival (DFS) were calculated to examine the associations between occult metastases and prognosis. RESULTS:Patients with occult metastases in axillary lymph nodes had poorer five-year DFS (RR = 0.930; 95% CI = 0.907-0.954) and OS (RR = 0.972; 95% CI = 0.954-0.990). Furthermore, the DFS (RR = 0.887; 95% CI = 0.810-0.972) and OS (RR = 0.896; 95% CI = 0.856-0.939) of patients with occult metastases were significantly lower after a ten-year follow-up. CONCLUSIONS: Occult metastases in the axillary lymph nodes are associated with poorer DFS andOS of patients with breast cancer. Occult metastases might serve as a predictive factor of survival outcomes in patients with breast cancer.
Authors: M H Galea; E Athanassiou; J Bell; B Dilks; J F Robertson; C W Elston; R W Blamey; I O Ellis Journal: J Pathol Date: 1991-11 Impact factor: 7.996
Authors: S Braun; B S Cevatli; C Assemi; W Janni; C R Kentenich; C Schindlbeck; D Rjosk; F Hepp Journal: J Clin Oncol Date: 2001-03-01 Impact factor: 44.544
Authors: Lee K Tan; Dilip Giri; Amanda J Hummer; Katherine S Panageas; Edi Brogi; Larry Norton; Clifford Hudis; Patrick I Borgen; Hiram S Cody Journal: J Clin Oncol Date: 2008-03-10 Impact factor: 44.544
Authors: Asif Loya; Merih Guray; Bryan T Hennessy; Lavinia P Middleton; Thomas A Buchholz; Vicente Valero; Aysegul A Sahin Journal: Cancer Date: 2009-04-15 Impact factor: 6.860